http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company Showcase
-
Absci Reports Second Quarter 2022 Financial Results and Business Update
-
Absci Reports Second Quarter 2022 Financial Results and Business Update
-
Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference
-
Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference
-
Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event
-
Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event
-
Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires
-
Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires
-
Absci Corporation (ABSI) Enters Multi-Program Collaboration with Emerging Biotech Partner
-
Absci Enters Multi-Program Collaboration with Emerging Biotech Partner
-
Absci Enters Multi-Program Collaboration with Emerging Biotech Partner
-
Absci Reports First Quarter 2022 Financial and Operating Results
-
Absci Reports First Quarter 2022 Financial and Operating Results
-
Absci to Participate in the BofA Securities 2022 Healthcare Conference
-
Absci to Participate in the BofA Securities 2022 Healthcare Conference
-
Absci Expands Drug Discovery Capabilities with Opening of Absci AI Research Lab in New York City
-
Absci Expands Drug Discovery Capabilities with Opening of Absci AI Research Lab in New York City
-
Absci Reports Full Year 2021 Financial and Operating Results
-
Absci Reports Full Year 2021 Financial and Operating Results
-
Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIA
-
Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIA
-
Absci Corporation (ABSI) Appoints Dr. Andreas Busch to its Board
-
Absci Appoints Dr. Andreas Busch to Board of Directors
-
Absci Appoints Dr. Andreas Busch to Board of Directors
-
Absci to Present at Global AI Conference NVIDIA GTC
-
Absci to Present at Global AI Conference NVIDIA GTC
-
Absci to Participate on Synthetic Biology Enabling Drug Discovery Panel at Cowen 42nd Annual Health Care Conference
-
Absci to Participate on Synthetic Biology Enabling Drug Discovery Panel at Cowen 42nd Annual Health Care Conference
-
Absci to Participate in Upcoming Investor Conferences
-
Absci to Participate in Upcoming Investor Conferences
-
Absci to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
Absci to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
Absci Corporation (ABSI) Enters Research Collaboration with Merck (MRK)
-
Absci Announces Research Collaboration with Merck
-
Absci Announces Research Collaboration with Merck
-
Absci to Participate in the 40th Annual J.P. Morgan Healthcare Conference
-
Absci to Participate in the 40th Annual J.P. Morgan Healthcare Conference
-
Absci to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
-
Absci to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
-
Absci to Participate in the 40th Annual J.P. Morgan Healthcare Conference
-
Absci to Participate in the 40th Annual J.P. Morgan Healthcare Conference
-
Absci Reports Third Quarter 2021 Financial and Operating Results
-
Absci Reports Third Quarter 2021 Financial and Operating Results
-
Absci to Participate in Upcoming November 2021 Investor Conferences
-
Absci to Participate in Upcoming November 2021 Investor Conferences
-
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
-
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
-
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs

